CV DEATH HAS A NEW OPPONENT
CV DEATH HAS A NEW OPPONENT

Consistent CV benefit of Empagliflozin (JARDIANCE) in the full spectrum of HF

Document ID: PC-PH-104046

06/12/2022

Author: Boehringer Ingelheim

Related content

 
PC-PH-104046
Production date: December 2022